| Literature DB >> 33746960 |
Emily Fraser1, Laura Denney1, Agne Antanaviciute1, Karl Blirando1, Chaitanya Vuppusetty1, Yuejuan Zheng1,2, Emmanouela Repapi3, Valentina Iotchkova3, Stephen Taylor3, Neil Ashley4, Victoria St Noble5, Rachel Benamore5, Rachel Hoyles5, Colin Clelland5, Joseph M D Rastrick6, Clare S Hardman1, Nasullah K Alham7, Rachel E Rigby1, Alison Simmons1, Jan Rehwinkel1, Ling-Pei Ho1,8.
Abstract
Idiopathic pulmonary fibrosis (IPF) is the most severe form of chronic lung fibrosis. Circulating monocytes have been implicated in immune pathology in IPF but their phenotype is unknown. In this work, we determined the immune phenotype of monocytes in IPF using multi-colour flow cytometry, RNA sequencing and corresponding serum factors, and mapped the main findings to amount of lung fibrosis and single cell transcriptomic landscape of myeloid cells in IPF lungs. We show that monocytes from IPF patients displayed increased expression of CD64 (FcγR1) which correlated with amount of lung fibrosis, and an amplified type I IFN response ex vivo. These were accompanied by markedly raised CSF-1 levels, IL-6, and CCL-2 in serum of IPF patients. Interrogation of single cell transcriptomic data from human IPF lungs revealed increased proportion of CD64hi monocytes and "transitional macrophages" with higher expression of CCL-2 and type I IFN genes. Our study shows that monocytes in IPF patients are phenotypically distinct from age-matched controls, with a primed type I IFN pathway that may contribute to driving chronic inflammation and fibrosis. These findings strengthen the potential role of monocytes in the pathogenesis of IPF.Entities:
Keywords: fibrosis; idiopathic pulmonary fibrosis; lung; macrophages; monocytes
Mesh:
Substances:
Year: 2021 PMID: 33746960 PMCID: PMC7973086 DOI: 10.3389/fimmu.2021.623430
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561